nancy lynn snyderman MD

Insider Reports History

Entity
Individual
Location
37 Pheasant Hill Road, Princeton, NJ
Signature
Kari L. Keese, as Attorney-in-fact for Nancy Lynn Snyderman MD
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by nancy lynn snyderman MD:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 17.5K $537K $30.72 May 31, 2024 Direct
Alkermes plc. Director Ordinary Shares 20.8K $501K $24.10 Jun 29, 2024 By the Snyderman Trust
Future Health ESG Corp. Director Common stock, par value $0.0001 per share 11.3K $134K $11.91 Oct 24, 2021 Indirect
Future Health ESG Corp. Director Common stock, par value $0.0001 per share 11.3K $134K $11.91 Oct 24, 2021 Direct
Alkermes plc. Director Ordinary Shares 4.64K $112K $24.10 Jun 29, 2024 Direct
Axonics, Inc. Director Common Stock 0 $0 $71.00 Nov 15, 2024 Direct
Axonics, Inc. Director Stock Option (Right to Buy) 0 $0 $49.96 Nov 15, 2024 Direct
Lyra Therapeutics, Inc. Director Stock Option 30K Jun 13, 2024 Direct
Alkermes plc. Director Restricted Stock Unit Award 0 Jun 29, 2024 Direct

Insider Reports Filed by nancy lynn snyderman MD

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AXNX Axonics, Inc. Nov 15, 2024 3 -$1.71M 4 Nov 15, 2024 Director
AXNX Axonics, Inc. Nov 7, 2024 1 $0 4 Nov 12, 2024 Director
ALKS Alkermes plc. Jun 29, 2024 3 -$35.3K 4 Jul 1, 2024 Director
LYRA Lyra Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
ALKS Alkermes plc. May 31, 2024 13 $115K 4 Jun 4, 2024 Director
ALKS Alkermes plc. Jul 7, 2023 3 -$42.7K 4 Jul 10, 2023 Director
LYRA Lyra Therapeutics, Inc. Jun 30, 2023 1 $0 4 Jul 5, 2023 Director
ALKS Alkermes plc. Jun 29, 2023 2 $0 4 Jun 30, 2023 Director
AXNX Axonics, Inc. Jun 26, 2023 1 $0 4 Jun 28, 2023 Director
AXNX Axonics, Inc. Aug 18, 2022 1 $0 4 Aug 22, 2022 Director
ALKS Alkermes plc. Jul 7, 2022 2 $0 4 Jul 8, 2022 Director
LYRA Lyra Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
ALKS Alkermes plc. Jun 14, 2022 3 -$18.9K 4 Jun 16, 2022 Director
ALKS Alkermes plc. Mar 4, 2022 1 $10K 4 Mar 8, 2022 Director
ALKS Alkermes plc. Dec 2, 2021 3 -$29.6K 4 Dec 3, 2021 Director
FHLT Future Health ESG Corp. Oct 24, 2021 2 $0 4 Oct 26, 2021 Director
AXNX Axonics, Inc. Oct 22, 2021 1 $0 4 Nov 2, 2021 Director
FHLT Future Health ESG Corp. Sep 14, 2021 1 $27.4K 4 Sep 16, 2021 Director
FHLT Future Health ESG Corp. Sep 9, 2021 0 $0 3 Sep 9, 2021 Director
ALKS Alkermes plc. Jun 14, 2021 2 $0 4 Jun 16, 2021 Director
LYRA Lyra Therapeutics, Inc. May 26, 2021 1 $0 4 May 28, 2021 Director
ALKS Alkermes plc. May 20, 2021 3 -$30.8K 4 May 21, 2021 Director